Efficacy and Safety of Lobeglitazone Versus Sitagliptin

Clinical trial NCT02480465 · UNKNOWN

Trial details

NCT number: NCT02480465
Sponsor: Chong Kun Dang Pharmaceutical
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Diabetes Mellitus, Type 2

Start date: 2015-01-01
Primary completion: 2016-12-01
Enrollment: 248

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.